CIK 0001818331
- Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851966622
- Phone
- +1 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −753 | 4,520 | ||
| 2024-10-29 | Stueland Katherine Chief Executive Officer | Option exercise | +3,874 | 107,580 | ||
| 2024-10-29 | Stueland Katherine Chief Executive Officer | Sale | −2,154 | $66.60 | $143K | 105,426 |
| 2024-10-29 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −3,874 | 23,244 | ||
| 2024-10-15 | Ryan Jason Director | Option exercise | +130 | 73,744 | ||
| 2024-10-15 | Ryan Jason Director | Option exercise · Restricted Stock Unit | −130 | 0 | ||
| 2024-10-15 | RUCH JOSHUA Director | Option exercise | +130 | 7,983 | ||
| 2024-10-15 | RUCH JOSHUA Director | Option exercise · Restricted Stock Unit | −130 | 0 | ||
| 2024-09-16 | Stueland Katherine Chief Executive Officer | Option exercise | +18,750 | 114,207 | ||
| 2024-09-16 | Stueland Katherine Chief Executive Officer | Sale | −10,501 | $37.59 | $395K | 103,706 |
| 2024-09-16 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −18,750 | 187,500 | ||
| 2024-09-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +7,197 | 47,107 | ||
| 2024-09-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2,635 | $37.59 | $99K | 44,472 |
| 2024-09-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 71,969 | ||
| 2024-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +2,462 | 40,805 | ||
| 2024-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −895 | $33.33 | $30K | 39,910 |
| 2024-09-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −2,462 | 22,159 | ||
| 2024-09-09 | Stueland Katherine Chief Executive Officer | Option exercise | +6,546 | 99,096 | ||
| 2024-09-09 | Stueland Katherine Chief Executive Officer | Sale | −3,639 | $33.33 | $121K | 95,457 |
| 2024-09-09 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,546 | 58,919 |
Page 26 of 36 · 718 trades